MDMA Statement on GAO Report on Implantable Medical Devices
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the U.S. Government Accountability Office’s (GAO) report on implantable medical devices (IMD) and their impact on health care costs:
“The GAO’s report on IMDs adds to the numerous studies that demonstrate how medical devices are improving patient care and playing a pivotal role in driving down costs.
“The GAO’s findings that hospital stays either steadily dropped or remained the same following procedures to implant medical devices highlight the impact medical technology has in increasing the quality of life.
“Medical technology played a pivotal role in decreasing hospital stays by 56 percent and death rates by 16 percent between 1980 and 2000. This is a remarkable achievement considering medical devices only represent 6 percent of total health care spending.
“Medical technology innovation continues to lead to fewer complications, less invasive procedures, and quicker recovery times, all which save patients and taxpayers money.
“MDMA will continue to work with Members of Congress and policy makers to share the stories about how medical technology drives down the costs of health care and improves patient outcomes.”
A copy of the report, “Trends in Beneficiaries Served and Hospital Resources Used in Implantable Medical Device Procedures,” can be found by clicking here.